Navigation Links
Grant will help patients with schizophrenia who smoke
Date:7/22/2008

A 200,000 grant has been awarded to researchers at Queen's to help establish why people with schizophrenia are three times more likely to smoke than the general population.

It is hoped the Medical Research Council award will help the scientists discover improved treatments for nicotine dependence - which can result in increased rates of illness and death from smoking-related diseases - as well as treatments for the symptoms of schizophrenia.

The funding will provide a three-year fellowship for Dr Ruth Barr, a psychiatrist in the School of Medicine and Dentistry.

Dr Barr hopes to build on research she has carried out during a fellowship at Harvard Medical School in Massachusetts on the effects of nicotine on attention and memory in schizophrenia.

The effects of nicotine withdrawal will be measured on around 40 volunteers, including both those with and without the condition.

Dr Barr said: "The reasons behind the increased need to smoke in patients with schizophrenia are unclear, although certain symptoms of this illness may increase vulnerability to nicotine dependence.

"Schizophrenia is associated with cognitive impairments including deficits in inhibitory control which may make it more difficult for patients to resist the impulse to smoke.

"We propose to investigate the effects of nicotine and nicotine withdrawal in smokers with and without schizophrenia on response inhibition, measured using a computer task.

"Cognitive abilities are believed to get worse during nicotine withdrawal and we want to establish if this deterioration is greater in patients with schizophrenia.

"In addition, we will investigate the mechanism of nicotine's effects on task performance using brain scanning and a measure of brain electrical activity.

"If we can understand why patients with schizophrenia are more likely to smoke it could enable us to develop new treatments for nicotine dependence and s
'/>"/>

Contact: Andrea Clements
a.clements@qub.ac.uk
Queen's University Belfast
Source:Eurekalert  

1

GOOD

Page: 1 2

Related medicine news :

1. Broad Institute earns grant to support pathbreaking diabetes study
2. Access Granted to Present at the Collaborative Communications Summit: Health Technology Investment Forum
3. With $2M NIH grant, FSU becomes 1 of worlds top imaging centers
4. NIH grant to strengthen IU and Purdue program to educate physician-scientists
5. Susan G. Komen for the Cure(R) Grants Gift to American Jewish Joint Distribution Committee (JDC) to Assist Rural Hungarian Women
6. NOTES research activities increase with grants from Olympus medical Systems totaling $1 million
7. Childrens Hospital Oakland receive NIH grants
8. The Foundation for Accelerated Vascular Research Grants $150,000 Wylie Scholar Award for Blood Vessel Research
9. FDA Grants AMDL Clearance to Market the AMDL-ELISA DR-70(R) (FDP) Blood Test for Monitoring Colorectal Cancer
10. Summary Judgment Granted for SEROQUEL(R) Patent Litigation
11. Hologic, Inc. Announces Grant of Early Termination of Antitrust Waiting Period for Third Wave Technologies, Inc. Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Grant will help patients with schizophrenia who smoke
Grant will help patients with schizophrenia who smoke
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 1RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 2RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 3RadioShack Partners With Seven Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 52566 4Injection Reverses Heart Attack Damage 4771 1Injection Reverses Heart Attack Damage 4771 2Injection Reverses Heart Attack Damage 4771 3Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 1Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 3
Other Medicine Technology:Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 2Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 3Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 4Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 5Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated 6Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 2Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 3Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 4Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 5Observational Studies Assess the Potential Impact of Limiting Erythropoiesis-Stimulating Agent Availability on Frequency of Blood Transfusions 6